Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares traded up 6.3% during trading on Thursday . The company traded as high as $1.19 and last traded at $1.18. 243,487 shares were traded during mid-day trading, an increase of 263% from the average session volume of 67,097 shares. The stock had previously closed at $1.11.
Cardiol Therapeutics Stock Performance
The company has a 50-day moving average of $1.30 and a 200-day moving average of $1.67.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- Using the MarketBeat Dividend Yield Calculator
- 5 Best Gold ETFs for March to Curb Recession Fears
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- How Technical Indicators Can Help You Find Oversold Stocks
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
